NCT03246022

Brief Summary

Obstructive sleep apnea syndrome (OSAS) causes nocturnal chronic intermittent hypoxia (CIH) that contributes to the development of hypertension. CIH profiles, including the its length, speed and intensity were widely different in individuals. Until recently, the influence of OSAS-related IH profiles on hypertension development has not been fully explored. The present study aimed to investigate the effects of different CIH properties on blood pressure (BP) and short-term blood pressure variability (BPV) in severe OSAS patients. Continuous positive airway pressure (CPAP) prevents the airway collapse, avoids the occurrence of intermittent hypoxemia and arousal, is the preferred treatment for OSAS and has been widely used in clinical. In theory, CPAP maintains upper airway patency and preserves ventilation, thereby inhibits the chain reaction over activation of the sympathetic nervous system and blood pressure regulating mechanism, thus CPAP treatment have adequate scientific basis to cause a substantial reduction arterial blood pressure, but controlled studies showed either no effect or only a minor decrease in arterial blood pressure by 1.4 and 2.5 mmHg respectively.The current, which type of combination of hypertension OSA patients can obtain the best antihypertensive benefit from CPAP therapy is still under debate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 5, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 11, 2017

Completed
8 months until next milestone

Study Start

First participant enrolled

April 3, 2018

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

March 29, 2022

Status Verified

August 1, 2021

Enrollment Period

3.7 years

First QC Date

August 5, 2017

Last Update Submit

March 28, 2022

Conditions

Keywords

blood pressure fluctuationhypertensioncontinuous positive airway pressureintermittent hypixaoxygen desaturation

Outcome Measures

Primary Outcomes (10)

  • awake systolic blood pressure(SBP)changes

    as the mean systolic blood pressure measurements during a supine resting period of 1 0minute at awake state

    change from Baseline Systolic Blood Pressure at 2 weeks

  • sleep systolic blood pressure(SBP)changes

    as the average of systolic blood pressure values during sleep

    change from Baseline Systolic Blood Pressure at 2 weeks

  • sympathetic-parasympathetic nerve balance changes

    Studies using spectral analysis of R-R intervals have reported that the power spectrum contains both low-frequency(LF,0.04-0.15 Hz)and high-frequency peaks(HF,0.15-0.5Hz),HF power reflects parasympathetic activity,whereas LF power primarily reflects sympathetic activity with a parasympathetic component.The LF-to-HF ratio(LF/HF)is commonly regarded as an index of sympathovagal balance

    change from Baseline Systolic Blood Pressure at 2 weeks

  • renin-angiotensin-aldosterone systemchanges

    as the levels of plasma angiotension ⅰ( Ang I) and angiotension ⅱ( Ang ⅱ) before and after CPAP treatment

    change from Baseline Systolic Blood Pressure at 2 weeks

  • AHI changes

    the combined number of apnea and hypopnea episodes per hour of sleep

    change from Baseline Systolic Blood Pressure at 2 weeks

  • TST90 changes

    percentage of sleep time with oxygen saturation \< 90%

    change from Baseline Systolic Blood Pressure at 2 weeks

  • oxygen desaturation index(ODI) changes

    oxygen desaturation index

    change from Baseline Systolic Blood Pressure at 2 weeks

  • event-related systolic blood pressure elevation (△SBP) changes

    as the gap between the peak value of postapneic SBP and lowest SBP during a obstructive respiratory event

    change from Baseline Systolic Blood Pressure at 2 weeks

  • systolic blood pressure(SBP)index

    as the number of △SBP\>10mmHg per hour of sleep time.

    change from Baseline Systolic Blood Pressure at 2 weeks

  • Desaturation rate

    The rate of fall in SpO2 was counted as the change in the percentage of SpO2 per second during apnea

    one night

Study Arms (2)

Group l

SBP index was less than 30% of AHI

Other: continuous positive airway pressure

Group 2

SBP index was less than 60% but more than 30%

Other: continuous positive airway pressure

Interventions

Continuous positive airway pressure (CPAP) prevents the airway collapse, avoids the occurrence of intermittent hypoxemia and arousal, is the preferred treatment for OSAS and has been widely used in clinical. The investigator would compare the effect of CPAP treatment on awake and sleep BP level at the first night and 2 weeks therapy among three groups. Moreover, whether or not the sympathetic-parasympathetic nerve balance and the renin-angiotensin-aldosterone system are different in three groups would also be evaluated.

Group 2Group l

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

1. age between 18 to 70 yrs; 2. newly diagnosed OSAS without treatment;

You may qualify if:

  • BP≤180/110mmHg,but≥140/90mmHg

You may not qualify if:

  • (1) patients who had been hospitalized for cardiac or respiratory exacerbation\<6wk prior to recruiting; (2) with autonomic nervous system diseases or endocrine disorders which might influence BP; (3) unwilling to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department Of Respiratory Medicine,Huai'an First People's Hospital,Nanjing Medical University

Huai'an, Jiangsu, 223300, China

Location

Related Publications (2)

  • Meng Z, Chen Y, Yang T, Sun B, Luo C, Wei G, Xie X, Gu Y, Ding N, Zhang X, Xu J. New perspective on exploring the predictive factors of blood pressure reduction during CPAP treatment in people with severe OSA and hypertension: a prospective observational study. BMJ Open Respir Res. 2023 May;10(1):e001560. doi: 10.1136/bmjresp-2022-001560.

  • Wang N, Meng Z, Ding N, Chen W, Zhang X, Huang M, Xu J. Oxygen desaturation rate as a novel intermittent hypoxemia parameter in severe obstructive sleep apnea is strongly associated with hypertension. J Clin Sleep Med. 2020 Jul 15;16(7):1055-1062. doi: 10.5664/jcsm.8396.

MeSH Terms

Conditions

Hypertension

Interventions

Continuous Positive Airway Pressure

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Zili Meng, Master

    Department Of Respiratory Medicine,Huai'an First People's Hospital,Nanjing Medical University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
The director of the of sleep center in Department of Respirology,Huai'an NO.1People's Hospital

Study Record Dates

First Submitted

August 5, 2017

First Posted

August 11, 2017

Study Start

April 3, 2018

Primary Completion

December 30, 2021

Study Completion

December 30, 2021

Last Updated

March 29, 2022

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations